Cited by 430Heart Failure Treatment and ManagementCardiovascular Function and Risk FactorsMechanical Circulatory Support Devices

Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

O'Connor, Christopher M., Abraham, William T., Albert, Nancy M., Clare, Robert, Gattis Stough, Wendy, Gheorghiade, Mihai, Greenberg, Barry H., Yancy, Clyde W. +2 more·2008·American Heart Journal

Abstract

Background Patients with heart failure (HF) are at high risk for mortality and rehospitalization in the early period after hospital discharge. We developed clinical models predictive of short-term clinical outcomes in a broad patient population discharged after hospitalization for HF.Methods The Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) registry is a comprehensive hospital-based registry and performance-improvement program for patients hospitalized with HF. Follow-up data were scheduled to be prospectively collected at 60 to 90 days postdischarge in a prespecified 10% sample. For the 4,402 patients included in this analysis, 19 prespecified potential predictor variables were used in a stepwise Cox proportional hazards model for all-cause mortality. Logistic regression including 45 potential variables was used to model mortality or rehospitalization.Results The 60- to 90-day postdischarge mortality rate was 8.6% (n = 481), and 29.6% (n = 1,715) were rehospitalized. Factors predicting early postdischarge mortality include age, serum creatinine, reactive airway disease, liver disease, lower systolic blood pressure, lower serum sodium, lower admission weight, and depression. Use of statins and beta-blockers at discharge was associated with significantly decreased mortality. The C-index of the model was 0.74. The most important predictors for the combined end point of death or rehospitalization were admission serum creatinine, systolic blood pressure, admission hemoglobin, discharge use of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker, and pulmonary disease. From this analysis, 8 factors identified to carry significant risk were selected for use in a point scoring system to predict the risk of mortality within 60 days after discharge, with a C-index of 0.72.Conclusions A substantial risk of mortality and mortality or rehospitalization is present in the first 60 to 90 days after discharge from a hospitalization for HF. Several factors were identified that signal high-risk patients. Application of these findings with a simple algorithm can distinguish patients who are low risk from those at high risk who may benefit from closer monitoring and aggressive evidence-based treatment.

Integrity signals

Registry

Crossref · 10.1016/j.ahj.2008.04.030

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
O'Connor, C. M., Abraham, W. T., Albert, N. M., Clare, R., Gattis Stough, W., Gheorghiade, M., Greenberg, B. H., Yancy, C. W., Young, J. B., & Fonarow, G. C.
Affiliations
  • The Ohio State University (US)
  • Cleveland Clinic (US)
  • Duke Clinical Research Institute (US)
  • Northwestern University (US)
  • University of California San Diego (US)
  • Baylor University Medical Center (US)
  • University of California, Los Angeles (US)
Venue
American Heart Journal
Publisher
Elsevier BV
Published
2008-10
Volume
156
Issue
4
Pages
662-673
ISSN
0002-8703 (ISSN-L)
OpenAlex
W2119254117
Cited by
430
References
36
Citations by year
2026: 6 · 2025: 17 · 2024: 13 · 2023: 17 · 2022: 11 · 2021: 28 · 2020: 17 · 2019: 26 · 2018: 30 · 2017: 37 · 2016: 31 · 2015: 32 · 2014: 41 · 2013: 29 · 2012: 41
FWCI
12.86
Type
journal article
Language
en
Open access
closed
Locations
  • American Heart Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
  • Physical Sciences › Engineering › Biomedical Engineering › Mechanical Circulatory Support Devices
Keywords
heart failure, post-discharge mortality, hospital readmission, risk prediction, serum creatinine, systolic blood pressure, statins, beta-blockers, ACE inhibitors, angiotensin receptor blockers, depression, risk scoring
MeSH terms
Adrenergic beta-Antagonists, Aged, Aged, 80 and over, Hypolipidemic Agents, Blood Pressure, Female, Heart Failure, Hospitalization, Humans, Male, Middle Aged, Patient Readmission, Prognosis, Registries, Proportional Hazards Models, Risk Assessment, Nomograms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review